Supernus Pharmaceuticals | SUPN - PE Price to Earnings

Stock Price
49.43
Daily Change
-1.77 -3.46%
Monthly
0.43%
Yearly
47.86%
Q2 Forecast
48.44

Supernus Pharmaceuticals reported 44.21 in PE Price to Earnings for its fiscal quarter ending in March of 2026.





Pe Change Date
Abbott 24.94 5.78 Mar/2026
ANI Pharmaceuticals 27.31 10.68 Mar/2026
Aurora Cannabis 23.27 0 Sep/2025
Bristol-Myers Squibb 9.08 0.2 Mar/2026
Cara Therapeutics 27.77 117.09 Sep/2021
Corcept Therapeutics 113.58 71.67 Mar/2026
Eisai 26.63 0.46 Dec/2025
Eli Lilly 40.27 0.06 Mar/2026
Novo Nordisk 12.78 0.01 Dec/2025
Pacira 38.58 14.1 Mar/2026
Perrigo 27.45 31.51 Mar/2026
Pfizer 9.32 5.16 Mar/2026
Supernus Pharmaceuticals 44.21 66.17 Mar/2026
United Therapeutics 20.42 3.1 Mar/2026